•
Jun 30, 2019

CRISPR Therapeutics Q2 2019 Earnings Report

Total Revenue
$318K
Previous year: $1.09M
-70.8%
EPS
-$1.01
Previous year: -$0.82
+23.2%
Gross Profit
-$39.2M
Previous year: -$24.5M
+59.8%
Cash and Equivalents
$428M
Previous year: $320M
+33.8%
Free Cash Flow
-$38.6M
Previous year: -$25.7M
+49.8%
Total Assets
$494M
Previous year: $353M
+40.0%

CRISPR Therapeutics

CRISPR Therapeutics